Association of temporal lobe inflammatory leukoencephalopathy with two B cell malignancies by Garzuly, Ferenc et al.
Az alábbi dokumentumot magáncélra töltötték le az eLitMed.hu webportálról. A dokumentum felhasználása a szerzôi jog szabályozása alá esik.
Ideggyogy Sz 2014;67(3–4):135–139. 135
ESETISMERTETÉS
ASSOCIATION OF TEMPORAL LOBE INFLAMMATORY
LEUKOENCEPHALOPATHY WITH TWO B CELL 
MALIGNANCIES 
Ferenc GARZULY1, Katalin HAHN2, László János IVÁNYI3, László KERESKAI5, Valéria GÁBOR1, 
Gábor G. KOVÁCS6, Herbert BUDKA6, Bernadette KALMAN4
1Markusovszky University Hospital, Department of Pathology; Szombathely
2Markusovszky University Hospital, Department of Neurology; Szombathely
3Markusovszky University Hospital, Department of Hematology; Szombathely
4Markusovszky University Hospital, Center for Molecular Medicine; Szombathely
5University of Pécs, Institute of Pathology; Pécs
6Medical University of Vienna, Institute of Neurology; Austria
GYULLADÁSOS TEMPORALIS LEUKOEN-
CEPHALOPATHIA EGYÜTTES MEGJELENÉSE KÉT 
B-SEJTES MALIGNOMÁVAL 
Garzuly F, MD, PhD; Hahn K, MD; Iványi LJ, MD, PhD; Kereskai
L, MD; Gábor V, MD; Kovács GG, MD, PhD; Budka H, MD,
MSc, Dhc; Kalman B, MD, PhD, DSc
Ideggyogy Sz 2014;67(3–4):135–139.
A klinikus idônként olyan beteggel is találkozik, akinek
egyszerre többféle, látszólag egymástól független betegsége
van. Ilyenkor az esetleges kapcsolat felderítése komoly
kihívást jelenthet számára. Ilyen bonyolult esetet mutatunk
be, amelyben két malignus B-sejtes betegség és gyulladásos
leukoencephalopathia fordult elô együtt. Az idôs férfi a
felvételt megelôzôen három nappal gyengeségre kezdett
panaszkodni, fejét fájdította, ismételten hányt, feledékeny
lett, étvágytalanná, deprimálttá, majd aluszékonnyá vált.
Klinikai, laboratóriumi, képalkotó és hisztológiai vizsgálatok
történtek, melyek során primer központi idegrendszeri lym-
phoma, a temporalis lebeny gyulladásos leukoen-
cephalopathiája és lappangó myeloma multiplex derült ki.
A beteg korábban kemoterápiában nem részesült. Korábbi
genomikai tanulmányok eredményei alapján feltételezhetô,
hogy a molekuláris abnormalitások B-sejtekben történô
szekvenciális akkumulációja vezetett elôször a myeloma
multiplex, majd a primer központi idegrendszeri lymphoma
kialakulásához, míg a temporalis lebeny leukoen-
cephalopathiája a lappangó myeloma multiplex paraneo-
plasiás következményeként értelmezhetô.
Kulcsszavak: myeloma multiplex, primer központi 
idegrendszeri lymphoma, B-sejtes malignoma, 
paraneoplasticus gyulladásos leukoencephalopthia,
szomatikus mutációk
Identification of etiological connections among virtually dis-
tinct diseases in a patient may be sometimes challenging.
We report a unique case with two B cell malignancies and
an inflammatory leukoencephalopathy. Three days prior to
admission, the elderly male patient developed fatigue,
headaches, recurrent vomiting, memory disturbances,
depression and somnolence. Clinical, laboratory and imag-
ing evaluations as well as post mortem histological studies
were performed. Simultaneous presence of primary central
nervous system B cell lymphoma, temporal lobe inflamma-
tory leukoencephalopathy and multiple (smoldering) myelo-
ma, was revealed by the detailed work up in the treatment-
naïve patient. Based on recent data from genomic studies,
we propose that a sequential evolution of molecular pathol-
ogy lead to the co-occurrence of multiple myeloma and pri-
mary central nervous system B cell lymphoma in this
patient, and interpret the development of the temporal lobe
leukoencephalopathy as a likely paraneoplastic complica-
tion of smoldering myeloma.
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paraneoplastic inflammatory leukoencephalopathy, 
somatic mutations 
Correspondent (levelezô szerzô): Ferenc GARZULY, MD, PhD, Department of Pathology, Markusovszky University
Hospital; 9700 Szombathely, Markusovszky Street 5. Phone: 36-94-515-412, e-mail: garzuly@t-online.hu
Érkezett: 2013. február 27. Elfogadva: 2013. március 26.
www.elitmed.hu
garzuly_UJ ISZ TUKOR ALAP ANGOL.qxd  2014.03.21.  16:14  Page 135
Az alábbi dokumentumot magáncélra töltötték le az eLitMed.hu webportálról. A dokumentum felhasználása a szerzôi jog szabályozása alá esik.
The co-occurrence of common diseases is fre-quently seen in clinical practice and causes no
diagnostic or therapeutic difficulties. In contrast,
the co-occurrence of rare and apparently independ-
ent conditions may pose major challenges in clini-
cal practice. It is particularly difficult to proceed
with the therapeutic intervention without knowing
whether or not there is a causal link among the
associated conditions. Here we report such a com-
plex case of a patient who presented with subacute
memory loss, personality and behavioral changes
and somnolence in our neurology department.
Case report
A 73 year old man was previously treated for
hypertension and atrial fibrillation. His new com-
plaints began three days prior to admission to the
neurology department, and included fatigue,
headaches, vomiting, memory problems, depres-
sion and personality changes. Neurological exam
revealed no focal findings, but lack of facial expres-
sions, psychomotor slowing, partial disorientation
in time, memory difficulties with encoding of new
information and somnolence when left alone. 
Abnormal laboratory results: cerebrospinal
fluid: protein 0.83 g/l (normal 0.12-0.6), WBC
10/µl (normal 0-10) with 90% lymphocytes, 10%
monocytes and no lymphoblasts; glucose 2.65
mmol/L (normal 2.20-3.90). 
3 Tesla MRI: A symmetric space occupying
lesion with edema, contrast enhancement and
decreased average diffusivity is visualized in the
medial thalami and inter-thalamic regions. The
right temporal lobe appears with narrowed gyri and
enlarged horn of the lateral ventricle. T1-weighted
images show a hypointense, and T2-weighted
images show a hyperintense lesion in this area
extending to the insular region, but excluding the
posterior part of the temporal lobe. In addition,
increased diffusion is noted on the DWI images in
the white matter, while equivocal diffusion alter-
ations are seen in the amygdale and hippocampus of
the right temporal lobe. T1-weighted images dis-
play no pathological changes in the hippocampal
and parahippocampal cortices (Figure 1A, B). 
These findings raised the suspicion of viral
(Herpes simplex virus - HSV) encephalitis or
tumor. Acyclovir, dexamethasone and enoxaparine
were initiated. However, subsequent tests were neg-
ative for HSV, tick borne encephalitis and West-
Nile viruses.
MRI-guided stereotactic biopsy of the right thal-
amus was performed at the Institute of
Neurosurgery, University of Pécs (UP), Dr. F.
Vetô. Histology: Primary large B cell lymphoma of
the brain with CD20+, Mum-1+, CD3-, and CD10-
immunophenotype.
For further management the patient was trans-
ferred to the Hematology Department of our hospi-
tal. 
Abdominal, mediastinal and pelvic computer
tomography revealed moderate hepatomegaly with-
out splenomegaly or mediastinal and abdominal
lymphadenomegaly. The cranium, vertebrae and
pelvis were free of osteolytic lesions. 
Laboratory findings: Serum immune-elec-
trophoresis: IgG 21.10 g/l (normal 8.0-17.0), IgA
0.29 g/l (normal 1.00-4.9), IgM 0.31 g/l (normal
0.50-3.2), Kappa-K chain 5.67 g/l (normal 2.00-
4.40), lambda-k chain 0.24 g/l (normal 1.1-2.4).
Interpretation: (1) 22.2% paraprotein in the gamma
region, (2) IgG Kappa monoclonal gammopathy.  
Bone marrow aspirate: > 20% clonally expanded
plasma cells; IgG kappa monoclonal gammopathy
and 22.2 g% M-protein. Interpretation: Multiple
myeloma. 
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Figure 1A Postgadolinium T1 weighted coronal image
of the thalamic lesion. The image shows bilateral
enhancing lesions representing the PCNSL
Figure 1B. T1 weighted native coronal image of right
temporal lobe. Thinning of the cortex, hypointensity
within the atrophied white matter and the enlargement of
the temporal horn are depicted
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Bone marrow (iliac crest) biopsy (Institute of
Pathology, PTE): The cellularity is below 20-30%
in many areas. Moderate CD138+ plasma cell pro-
liferation with mostly CD20+, CD56- co-staining is
seen in an uneven diffuse and cluster-like distribu-
tion occasionally reaching 10-15%. IgG kappa
chain positivity is abundant. 
Comparison of the bone marrow and thalamus
biopsies: The brain biopsy (PCNSL) contained cells
of markedly more immature phenotype, predomi-
nantly immunoblastoid cells with central nucleolus,
a few with plasmocytoid features, but repeatedly
with CD138- and strongly CD20+ staining and with
a proliferation rate of >70% that would be very
unusual in MM. Analyses of IgG heavy chain gene
rearrangements in the brain - and bone marrow -
derived specimens revealed multiple, but distinct
rearrangement patterns, supporting two clonally
different processes (B cell PCNSL in the brain and
plasma cell myeloma in the bone marrow). 
The patient received 1x intravenous (3 g/m2) and
3x intrathecal methotrexate treatment for the
PCNSL. In a week, severe myelosuppression devel-
oped. The anemia was treated with RBC concen-
trate, while the neutropenia was managed with a
granulocyte colony-stimulating factor preparation.
For the treatment of MM, dexamethasone was
administered. His neurological condition was
unchanged, but he developed fever and died of sep-
sis.
Autopsy: The immediate cause of death was
pneumonia with abscesses accompanied by a hema-
tological spread. Bone fragments showed decalcifi-
cation and hypocellular marrow with significantly
decreased erythro- and myelopoesis. Atypia was
observed among megakariocytes. Plasma cell pro-
liferation was seen with cytomorphological atypia
and uneven distribution. Internal organs were free
of MM (“smoldering myeloma”). 
Both thalami were moderately swollen.
Lymphocytic parenchymal infiltration accompanied
by astrogliosis, and perivascular infiltration at the
lesion edges, were seen in the medial nuclei of both
thalami (Figure 2.). The tumor cells were small and
medium sized with fine chromatin structure, round
shape and occasionally prominent nucleoli. The
cytoplasm appeared thin and slightly eosinophilic.
Immunohistochemistry revealed almost 100%
CD20+ and CD79a+ tumor cells. There were a few
CD8+ T lymphocytes localized around blood vessels
and in inflammatory infiltrates. 
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Figure 2. H&E stained section and IHC of the PCNSL
from the thalami. Small and medium size tumor cells
with fine chromatin structure and round shaped, occa-
sionally prominent nucleoli are demonstrated. The cyto-
plasm appears thin and slightly eosinophilic. Inset: IHC
reveals strong CD20 positivity of the cells
Figure 3A. Woelcke stained section of the right hemi-
sphere. Extensive loss of myelin is demonstrated in the
temporal lobe
Figure 3B. Anti-CD8 immunohistochemistry of the tem-
poral lobe. Perivascular and parenchymal infiltration of
CD8 lymphocytes is seen in the white matter of the right
temporal lobe
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The right temporal lobe had thin gyri and gray-
ish, softened WM. The WM was rarified and cystic
(Figure 3A) with only a few remaining fragments
of SMI31+ axonal and myelin fragments amidst
prominent glial scarring involving gemistocytes,
fibrillary astrocytes and scattered macrophages.
Strong CD68+ staining was noted in lipid-laden
macrophages. Predominantly CD8+ cytotoxic T
and CD20+ B cell infiltration occurred in perivas-
cular distribution, without signs of malignancy.
CD8 cells diffusely infiltrated the parenchyma
(Figure 3B). The cortical gray matter was rarified
and focally spongiform with some inflammatory
activity extending from the WM, but without
microglial nodules or gliosis. Immunohisto che -
mistry was negative for HSV-1,-2, JC and SV40
viruses. These observations suggested an inflam-
matory leukoencephalopathy of non-viral origin.
Epstein-Barr virus detection was equivocal due to
poor RNA quality. Direct immunfluorescence
revealed no IgG and complement C3 deposition in
the temporal WM specimens.
Discussion
The clinical work up established that the patient had
two diseases of the CNS: 1. a primary B cell CNS
lymphoma occupying both thalami and 2. a white
matter disease affecting almost the entire right tem-
poral lobe and causing atrophy. In addition to the
CNS pathology, this case was further complicated
by the clinical recognition of a smoldering multiple
myeloma that only affected the bone marrow and
caused no apparent complaints. Unfortunately, the
patient died from sepsis after 1.5 months of immune
suppressive therapy.
In our work up two major questions arose
1. Could the co-occurrence of two B cell malig-
nancies (PCNSL and MM) be a co-incidence, or
related to a common molecular cause in this patient
who was treatment naive at the time of clinical
recognition? Unless treatment of MM by
chemotherapy induced immune suppression and a
secondary cancer (e.g. PCNSL), the simultaneous
detection of two B cell malignancies in a single
patient is unusual (1). Searching Pubmed, we
found a single report describing a tri-lineage hema-
tological disease with sideroblastic anemia, MM
and B-cell non-Hodgkin’s lymphoma (2). The
Multiple Myeloma Genomics Initiative using mas-
sively parallel sequencing of tumor genomes and
the corresponding normal DNAs revealed that the
number of somatic point mutations in the tumor is
high (2.9 / million bases translating into 7,450
mutations in a tumor), and the mutations involve
several functionally important genes that define a
mechanistic framework of tumorgenesis (3).
Relevant to our case, mutations were detected in
regions of known somatic hypermutations which
comprise immuno globulin-coding genes and a
lymphoid oncogene, BCL6. Further, mutations
were observed within non-coding regions of
BCL7A, a putative tumor suppressor gene involved
in the B-cell malignancy, Burkitt lymphoma. In the
light of these findings we propose that the accumu-
lation of somatic mutations in malignant cells of
the bone marrow may result in some clonal diver-
sity over time. Mutations affecting lymphoid onco-
genes or tumor suppressor genes may occur in
myeloma subclones and drive the genesis of a new,
phenotypically different B cell malignancy. If
these mutated daughter clones express appropriate
adhesion molecules, they may migrate to the CNS
and give rise to PCNSL. Therefore, the PCNSL in
this patient could be explained as a result of the
somatic molecular changes evolving in the bone
marrow B cell lineages which primarily cause MM
and subsequently also PCNSL.
2. What could be the cause of the observed tem-
poral lobe leukoencephalopathy? Vascular, trau-
matic, metabolic or inherited disorders could be
readily excluded based on clinical and histological
features. Despite the absence of characteristic signs
of Herpes Simplex (HS) encephalitis (the patient
had no fevers, the MRI showed a chronic lesion
predominantly in the white matter without the
involvement of the cortex, and there was no hemor-
rhagic transformation in this lesion), this diagnosis
was assumed as a potential, treatable cause of tem-
poral lobe pathology and empirically treated until
serological, virological and / or histopathological
studies from the stereotactic brain biopsy unequiv-
ocally excluded the presence of this and several
other viruses (HSV-1, -2, West Nile, JC, SB40).
When PCNSL in the thalami was recognized, the
possibility of paraneoplastic origin of the temporal
lobe pathology arose. The association between
paraneoplastic limbic encephalitis and peripheral B
cell lymphomas is well known (4). However, a
paraneoplastic mechanism requires chronic expo-
sure to and priming of the adaptive immune system
by the lymphoma antigens in the peripheral
immune system. Therefore, it is difficult to associ-
ate a paraneoplastic mechanism with a lymphoma
restricted to the CNS, and the literature is also
rather spares in this regard.
Could the temporal lobe pathology still be para-
neoplastic in origin? The bone marrow malignancy
caused no complaints, but the disease probably per-
sisted for years as a smoldering myeloma, allowing
the development of a long-standing, secondary
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pathology in the CNS. However, both the MR
images and the pathology work up showed that the
limbic system was largely spared, while the white
matter of the right temporal lobe was predominant-
ly affected in this patient. The histological studies
also suggested that it was the inflammatory and
spongiosus white matter lesion that extended
towards the gray matter of the right temporal lobe,
not the other way around, and beside the extensive
white matter involvement, the gray matter patholo-
gy was sparse. Such a temporal lobe leukoen-
cephalopathy, would not be compatible with para-
neoplastic limbic encephalitis that primarily affects
the mesial temporal lobe region and gray matter
structures (5). In the absence of IgG kappa parapro-
tein, C3 complement, viruses and malignant B cells
in the right temporal lobe, the inflammatory
leukoencephalopathy with many infiltrating CD8
cells and myelin and axonal loss was likely a T cell
driven paraneoplastic leukoencephalopathy and
mostly resembled the histological characteristics of
ADEM (acute demyelinating encephalomyelitis).
The lesion’s MRI characteristics were also compat-
ible with this conclusion. ADEM-like paraneoplas-
tic leukoencephalomyelitides in association with
MM were described without the presence of com-
mon paraneoplastic antibodies or microorganisms
(6–8). However, in the light of the long standing
nature of and lack of anti-myelin paraproteins in the
CNS WM lesion, our observation, similar to the
previously published cases, only provides circum-
stantial evidence for the existence of a paraneoplas-
tic ADEM-like pathology and may be more appro-
priate to call it inflammatory leukoencephalopathy
associated with MM. 
As inflammatory CNS lesions can be caused by
Epstein-Barr virus (EBV) infection in both pedi-
atric (9, 10) and adult patients (11, 12), the ethio-
logical involvement of EBV in the temporal lobe
pathology of this patient also had to be considered.
However, PCNSLs are typically negative for EBV
in immunocompetent patients, as was our patient
too at the time of PCNSL diagnosis. Nevertheless,
a recent report described EBV detection in a very
low frequency of PCNS in immunocompetent indi-
viduals (13). Unfortunately, testing for EBV in the
PCNSL lesion failed to provide unequivocal result
in our patient. Considering the typically EBV nega-
tive nature of PCNSL in an immunocompetent
patient, the cause of the temporal lobe lesion in our
case appears unlikely to be EBV-related and is
mainly compatible with an inflammatory leukoen-
cephalopathy, possibly of paraneoplastic origin, in
association with MM.
Conclusions
The current case exemplifies the complexity of MM
pathology and suggests that clonal diversity and
autoimmune processes may contribute to associated
neurological complications. 
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